CDIP - 58可衡量肉毒杆菌毒素治疗颈部肌张力障碍的效果。

CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.

作者信息

Cano S J, Hobart J C, Edwards M, Fitzpatrick R, Bhatia K, Thompson A J, Warner T T

机构信息

Department of Clinical Neurosciences, Royal Free and University College Medical School, London, UK.

出版信息

Neurology. 2006 Dec 26;67(12):2230-2. doi: 10.1212/01.wnl.0000249310.25427.f2.

DOI:10.1212/01.wnl.0000249310.25427.f2

PMID:17190951

Abstract

We compared the responsiveness of the Cervical Dystonia Impact Profile (CDIP-58), Medical Outcome Study Short Form-Health Survey (SF-36), Functional Disability Questionnaire (FDQ), and Pain and Activities of Daily Living subscales of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in participants with cervical dystonia treated with botulinum toxin A. Subscales of CDIP-58 were more sensitive in detecting statistical and clinical change than comparable subscales of the SF-36, FDQ, and TWSTRS.

摘要

我们比较了肉毒杆菌毒素A治疗的颈部肌张力障碍患者中，颈部肌张力障碍影响量表（CDIP-58）、医学结局研究简明健康调查（SF-36）、功能残疾问卷（FDQ）以及多伦多西部痉挛性斜颈评定量表（TWSTRS）的疼痛和日常生活活动分量表的反应性。CDIP-58的分量表在检测统计学和临床变化方面比SF-36、FDQ和TWSTRS的可比分量表更敏感。